Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study
Titel:
Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study
Auteur:
Wedemeyer, H. Aleman, S. Andreone, P. Blank, A. Brunetto, M. Bogomolov, P. Chulanov, V. Geyvandova, N. Hilgard, G. Mamonova, N. Merle, U. Viacheslav, M. Sagalova, O. Stepanova, T. zur Wiesch, J. Schulze Zotov, S. Zeuzem, S. Lampertico, P.